We identified 14 CpG islands of LOXL2 (i.e., cg20981791, cg20142986, cg24531955, cg17804498, cg09535960, cg04028450, cg10090386, cg09042448, cg18233786, cg22996912, cg00558156, cg25074071, cg05365729, and cg04259752) that were significantly and negatively associated with LOXL2 gene expression in cervical carcinoma (Supplementary Table 4). This evidence concerns the gene LOXL2 and cervical carcinoma.